ClinicaliQ Trial Snapshot
- Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population — Recruiting • Rheumatology • NCT07177209.
- Sponsor: Pfizer.
Verify eligibility, endpoints and current status on the original source registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
Eligibility Snapshot
- Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
- Patient enrolled in IBD registry from 2009 2. >18 years at time of diagnosis. 3. Diagnosis of Ulcerative Colitis.
- Patient data entered during the study period. 5. Minimum duration of data post UC diagnosis (Cohort A: 6 months, Cohort B-D 6 months)
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.